Literature DB >> 9622212

Factor X Frankfurt I: molecular and functional characterization of a hereditary factor X deficiency (Gla+25 to Lys).

I M Nöbauer-Huhmann1, W Höller, B Krinninger, P L Turecek, G Richter, I Scharrer, E Forberg, H H Watzke.   

Abstract

A family with hereditary factor X deficiency is presented. One member, a 25-year-old man, showed a mild bleeding tendency. His factor X activity (extrinsic: 56%; intrinsic: 55%; Russell's viper venom: 57%) and his level of circulating factor X antigen (55% of normal) were markedly reduced. Analysis of his factor X gene revealed a single point mutation within exon II resulting in the substitution of +25 Gla (GAA) by Lys (AAA). The mutation was determined by gene analysis to be heterozygous in this patient, his mother and one of his brothers. Clotting assays of factor X purified from the plasma of the index patient revealed an activity of 89% of normal upon activation with Russell's viper venom, 77% of normal in the intrinsic and 81% of normal in the extrinsic coagulation pathway. The mutation responsible for the substitution of Lys for Gla+25 was introduced into an expression plasmid containing a wild type factor X cDNA and expressed in a mammalian cell line. Factor X antigen levels in the cell lysates and in the supernatant were identical in the mutant and wild type constructs. The specific activity of the factor X expressed from the mutant construct was 3% compared with the wild type construct. These data demonstrate that the substitution of Lys for Gla+25 results not only in a reduced level of factor X in the affected family members, but also in a substantial loss of specific factor X activity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9622212

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  2 in total

1.  Factor X M402T: a homozygous missense mutation identified as the cause of cross-reacting material-reduced deficiency.

Authors:  Yushi Chikasawa; Keiko Shinozawa; Kagehiro Amano; Kyoichi Ogata; Takeshi Hagiwara; Takashi Suzuki; Hiroshi Inaba; Katsuyuki Fukutake
Journal:  Int J Hematol       Date:  2014-07-27       Impact factor: 2.490

2.  Structure and dynamics of zymogen human blood coagulation factor X.

Authors:  Divi Venkateswarlu; Lalith Perera; Tom Darden; Lee G Pedersen
Journal:  Biophys J       Date:  2002-03       Impact factor: 4.033

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.